Serological biomarkers of type I, III and IV collagen turnover are associated
top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and...
IBDENC ENC
- Jul 28, 2022
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. Millie...
IBDENC ENC
- Jul 25, 2022
Metabolome Changes With Diet-Induced Remission in Pediatric Crohn’s Disease
M Ghiboub, S Penny, C M Verburgt, R Sigall Boneh, E Wine, A Cohen, K A Dunn, D M Pinto, M A Benninga, W J de Jonge, A Levine, J E Van...
IBDENC ENC
- Jul 23, 2022
Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel
Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease. Janet E Hill, Juan-Nicolás...
IBDENC ENC
- Jul 21, 2022
Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel Disease
Omer S Omer, Arnulf Hertweck, Luke B Roberts, Jonathan W Lo, Jennie N Clough, Ian Jackson, Eirini D Pantazi, Peter M Irving, Tom T...
IBDENC ENC
- Jul 20, 2022
Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota
Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with...
IBDENC ENC
- Jul 16, 2022
Stringent screening strategy significantly reduces reactivation rates of tuberculosis
Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on...
IBDENC ENC
- Jul 15, 2022
Faecal Metabolomics in Paediatric Inflammatory Bowel Disease: A Systematic Review
Jasmijn Z Jagt, Charlotte M Verburgt, Ralph de Vries, Nanne K H de Boer, Marc A Benninga, Wouter J de Jonge, Johan E van Limbergen, Tim G...
IBDENC ENC
- Jul 13, 2022
Etrolizumab versus adalimumab or placebo as induction therapy
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase...
bottom of page